SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-18-036369
Filing Date
2018-02-08
Accepted
2018-02-08 16:51:58
Documents
2
Group Members
BLINK ACQUISITION CORP.SANOFI-AVENTIS AMERIQUE DU NORDSANOFI-AVENTIS NA HOLDING, INC.

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d536602dsctota.htm SC TO-T/A 27688
2 EXHIBIT (A)(5)(G) d536602dex99a5g.htm EX-99.(A)(5)(G) 13641
  Complete submission text file 0001193125-18-036369.txt   43105
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filed by) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 225 2ND AVENUE WALTHAM MA 02451
Business Address 225 2ND AVENUE WALTHAM MA 02451 781-663-4400
Bioverativ Inc. (Subject) CIK: 0001681689 (see all company filings)

IRS No.: 813461310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-89883 | Film No.: 18586363
SIC: 2834 Pharmaceutical Preparations